These independent CME/CE activities are supported by an educational grant from
Boehringer Ingelheim Pharmaceuticals, Inc.and GlaxoSmithKline



     Pulmonology Mastery in
  COPD
  1. Course List
Chair
Barry J. Make, MD
  • Co-Director, COPD Program
  • Division of Pulmonary and Critical Care Medicine
  • National Jewish Health
  • Denver, Colorado

  • Contributing Editor
    Sidney S. Braman, MD
  • Professor of Medicine
  • Mount Sinai Hospital/National Jewish Health Respiratory Institute
  • Division of Pulmonary Critical Care and Sleep Medicine
  • New York, New York
  • Disclosure Information
    Barry J. Make, MD   has received consulting fees from AstraZeneca, Boehringer Ingelheim, Forest Pharmaceuticals, MedImmune, LLC, Merck & Co Inc, Novartis Pharmaceuticals Corporation, and Sunovian Pharmaceuticals Inc; fees for non-CME/CE services from Boehringer Ingelheim, Forest Pharmaceuticals, GlaxoSmithKline, and Pfizer Inc; and conducted contracted research for Actelion Pharmaceuticals Ltd, Boehringer Ingelheim, Forest Pharmaceuticals, GlaxoSmithKline, NABI Biopharmaceuticals, and Sunovian Pharmaceuticals Inc. Dr. Make has disclosed that his presentation will reference the unlabeled/unapproved use of azithromycin.

    Sidney S. Braman, MD   has received honoraria from Covidien, part of Medtronic Minimally Invasive Therapies Group, and Genentech, a member of the Roche Group; and has received consulting fees from AstraZeneca and Sunovion Pharmaceuticals Inc.